Style de citation APA (7e éd.)

Heger, J., Mattlener, J., Kaul, H., Ferdinandus, J., Schneider, J., Schleifenbaum, J. K., . . . Borchmann, P. (2026). MRD-2 in the GHSG HD21 trial assessed by a validated circulating tumor DNA sequencing assay. Blood, 147(19), . https://doi.org/10.1182/blood.2025031089

Style de citation Chicago (17e éd.)

Heger, Jan-Michel, et al. "MRD-2 in the GHSG HD21 Trial Assessed by a Validated Circulating Tumor DNA Sequencing Assay." Blood 147, no. 19 (2026). https://doi.org/10.1182/blood.2025031089.

Style de citation MLA (9e éd.)

Heger, Jan-Michel, et al. "MRD-2 in the GHSG HD21 Trial Assessed by a Validated Circulating Tumor DNA Sequencing Assay." Blood, vol. 147, no. 19, 2026, https://doi.org/10.1182/blood.2025031089.